An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells. Nicholas S Wilson, Becky Yang, +17 authors, Annie Yang, Stefanie Loeser, Scot Marsters, David Lawrence, Yun Li, Robert Pitti, Klara Totpal, Sharon Yee, Sarajane Ross, Jean-Michel Vernes, Yanmei Lu, Cam Adams, Rienk Offringa, Bob Kelley, Sarah Hymowitz, Dylan Daniel, Gloria Meng, Avi Ashkenazi. less Cancer Cell, 2011 Jan 22; 19(1). PMID: 21251615 Highly Cited.
|
Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses. Halina M Trist, Peck Szee Tan, +9 authors, Bruce D Wines, Paul A Ramsland, Eva Orlowski, Janine Stubbs, Elizabeth E Gardiner, Geoffrey A Pietersz, Stephen J Kent, Ivan Stratov, Dennis R Burton, P Mark Hogarth. less J Immunol, 2013 Dec 18; 192(2). PMID: 24342805 Free PMC article.
|
Nivolumab plus ipilimumab in advanced melanoma. Jedd D Wolchok, Harriet Kluger, +21 authors, Margaret K Callahan, Michael A Postow, Naiyer A Rizvi, Alexander M Lesokhin, Neil H Segal, Charlotte E Ariyan, Ruth-Ann Gordon, Kathleen Reed, Matthew M Burke, Anne Caldwell, Stephanie A Kronenberg, Blessing U Agunwamba, Xiaoling Zhang, Israel Lowy, Hector David Inzunza, William Feely, Christine E Horak, Quan Hong, Alan J Korman, Jon M Wigginton, Ashok Gupta, Mario Sznol. less N Engl J Med, 2013 Jun 04; 369(2). PMID: 23724867 Free PMC article. Highly Cited.
|
CD28-mediated co-stimulation: a quantitative support for TCR signalling. Oreste Acuto, Frédérique Michel. Nat Rev Immunol, 2003 Dec 04; 3(12). PMID: 14647476 Highly Cited. Review.
|
Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells. Mark J Selby, John J Engelhardt, +4 authors, Michael Quigley, Karla A Henning, Timothy Chen, Mohan Srinivasan, Alan J Korman. less Cancer Immunol Res, 2014 Apr 30; 1(1). PMID: 24777248 Highly Cited.
|
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Michael A Curran, Welby Montalvo, Hideo Yagita, James P Allison. Proc Natl Acad Sci U S A, 2010 Feb 18; 107(9). PMID: 20160101 Free PMC article. Highly Cited.
|
OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer. Ryan Montler, R Bryan Bell, +8 authors, Colin Thalhofer, Rom Leidner, Zipei Feng, Bernard A Fox, Allen C Cheng, Tuan G Bui, Christopher Tucker, Helena Hoen, Andrew Weinberg. less Clin Transl Immunology, 2016 May 20; 5(4). PMID: 27195113 Free PMC article.
|
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Enfu Hui, Jeanne Cheung, +8 authors, Jing Zhu, Xiaolei Su, Marcus J Taylor, Heidi A Wallweber, Dibyendu K Sasmal, Jun Huang, Jeong M Kim, Ira Mellman, Ronald D Vale. less Science, 2017 Mar 11; 355(6332). PMID: 28280247 Free PMC article. Highly Cited.
|
The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Todd N Eagar, Nitin J Karandikar, Jeffrey A Bluestone, Stephen D Miller. Eur J Immunol, 2002 Mar 29; 32(4). PMID: 11920563
|
Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials--Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine storm. S Vessillier, D Eastwood, +6 authors, B Fox, J Sathish, S Sethu, T Dougall, S J Thorpe, R Thorpe, R Stebbings. less J Immunol Methods, 2015 May 12; 424. PMID: 25960173 Free PMC article.
|
OX40 is a potent immune-stimulating target in late-stage cancer patients. Brendan D Curti, Magdalena Kovacsovics-Bankowski, +20 authors, Nicholas Morris, Edwin Walker, Lana Chisholm, Kevin Floyd, Joshua Walker, Iliana Gonzalez, Tanisha Meeuwsen, Bernard A Fox, Tarsem Moudgil, William Miller, Daniel Haley, Todd Coffey, Brenda Fisher, Laurie Delanty-Miller, Nicole Rymarchyk, Tracy Kelly, Todd Crocenzi, Eric Bernstein, Rachel Sanborn, Walter J Urba, Andrew D Weinberg. less Cancer Res, 2013 Nov 02; 73(24). PMID: 24177180 Free PMC article. Highly Cited.
|
Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40. E Oflazoglu, I J Stone, +6 authors, L Brown, K A Gordon, N van Rooijen, M Jonas, C-L Law, I S Grewal, H-P Gerber. less Br J Cancer, 2008 Dec 11; 100(1). PMID: 19066610 Free PMC article.
|
Affinity and cross-reactivity engineering of CTLA4-Ig to modulate T cell costimulation. Zhenghai Xu, Veronica Juan, +6 authors, Alexander Ivanov, Zhiyuan Ma, Dixie Polakoff, David B Powers, Robert B Dubridge, Keith Wilson, Yoshiko Akamatsu. less J Immunol, 2012 Sep 29; 189(9). PMID: 23018459
|
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. P Waterhouse, J M Penninger, +6 authors, E Timms, A Wakeham, A Shahinian, K P Lee, C B Thompson, H Griesser, T W Mak. less Science, 1995 Nov 10; 270(5238). PMID: 7481803 Highly Cited.
|
Superantigens hyperinduce inflammatory cytokines by enhancing the B7-2/CD28 costimulatory receptor interaction. Revital Levy, Ziv Rotfogel, +5 authors, Dalia Hillman, Andrey Popugailo, Gila Arad, Emmanuelle Supper, Farhat Osman, Raymond Kaempfer. less Proc Natl Acad Sci U S A, 2016 Oct 30; 113(42). PMID: 27708164 Free PMC article.
|
The in vitro resistance of IgG2 to proteolytic attack concurs with a comparative paucity of autoantibodies against peptide analogs of the IgG2 hinge. Randall J Brezski, Allison Oberholtzer, Brandy Strake, Robert E Jordan. MAbs, 2011 Nov 30; 3(6). PMID: 22123056 Free PMC article.
|
CTLA-4 blockade in tumor models: an overview of preclinical and translational research. Joseph F Grosso, Maria N Jure-Kunkel. Cancer Immun, 2013 Feb 08; 13. PMID: 23390376 Free PMC article. Highly Cited. Review.
|
Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients. Emanuela Romano, Monika Kusio-Kobialka, +7 authors, Periklis G Foukas, Petra Baumgaertner, Christiane Meyer, Pierluigi Ballabeni, Olivier Michielin, Benjamin Weide, Pedro Romero, Daniel E Speiser. less Proc Natl Acad Sci U S A, 2015 Apr 29; 112(19). PMID: 25918390 Free PMC article. Highly Cited.
|
Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators. Isabelle Le Mercier, J Louise Lines, Randolph J Noelle. Front Immunol, 2015 Sep 09; 6. PMID: 26347741 Free PMC article. Highly Cited. Review.
|
Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Xuguang Tai, François Van Laethem, +9 authors, Leonid Pobezinsky, Terry Guinter, Susan O Sharrow, Anthony Adams, Larry Granger, Michael Kruhlak, Tullia Lindsten, Craig B Thompson, Lionel Feigenbaum, Alfred Singer. less Blood, 2012 Mar 10; 119(22). PMID: 22403258 Free PMC article. Highly Cited.
|
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. Michael A Postow, Jason Chesney, +18 authors, Anna C Pavlick, Caroline Robert, Kenneth Grossmann, David McDermott, Gerald P Linette, Nicolas Meyer, Jeffrey K Giguere, Sanjiv S Agarwala, Montaser Shaheen, Marc S Ernstoff, David Minor, April K Salama, Matthew Taylor, Patrick A Ott, Linda M Rollin, Christine Horak, Paul Gagnier, Jedd D Wolchok, F Stephen Hodi. less N Engl J Med, 2015 Apr 22; 372(21). PMID: 25891304 Free PMC article. Highly Cited.
|
Tumor immunotherapy directed at PD-1. Antoni Ribas. N Engl J Med, 2012 Jun 05; 366(26). PMID: 22658126 Highly Cited.
|
Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. K S Hathcock, G Laszlo, +3 authors, H B Dickler, J Bradshaw, P Linsley, R J Hodes. less Science, 1993 Nov 05; 262(5135). PMID: 7694361 Highly Cited.
|
Translational control of interleukin 2 messenger RNA as a molecular mechanism of T cell anergy. J A Garcia-Sanz, D Lenig. J Exp Med, 1996 Jul 01; 184(1). PMID: 8691129 Free PMC article.
|
CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition. Elizabeth I Buchbinder, Anupam Desai. Am J Clin Oncol, 2015 Nov 13; 39(1). PMID: 26558876 Free PMC article. Highly Cited. Review.
|
Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response. Pia Kvistborg, Daisy Philips, +13 authors, Sander Kelderman, Lois Hageman, Christian Ottensmeier, Deborah Joseph-Pietras, Marij J P Welters, Sjoerd van der Burg, Ellen Kapiteijn, Olivier Michielin, Emanuela Romano, Carsten Linnemann, Daniel Speiser, Christian Blank, John B Haanen, Ton N Schumacher. less Sci Transl Med, 2014 Sep 19; 6(254). PMID: 25232180 Highly Cited.
|
Structural basis for the recognition of human cytomegalovirus glycoprotein B by a neutralizing human antibody. Nadja Spindler, Uschi Diestel, +5 authors, Joachim D Stump, Anna-Katharina Wiegers, Thomas H Winkler, Heinrich Sticht, Michael Mach, Yves A Muller. less PLoS Pathog, 2014 Oct 10; 10(10). PMID: 25299639 Free PMC article.
|
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma. Dirk Schadendorf, F Stephen Hodi, +7 authors, Caroline Robert, Jeffrey S Weber, Kim Margolin, Omid Hamid, Debra Patt, Tai-Tsang Chen, David M Berman, Jedd D Wolchok. less J Clin Oncol, 2015 Feb 11; 33(17). PMID: 25667295 Free PMC article. Highly Cited.
|
CTLA-4 control over Foxp3+ regulatory T cell function. Kajsa Wing, Yasushi Onishi, +5 authors, Paz Prieto-Martin, Tomoyuki Yamaguchi, Makoto Miyara, Zoltan Fehervari, Takashi Nomura, Shimon Sakaguchi. less Science, 2008 Oct 11; 322(5899). PMID: 18845758 Highly Cited.
|
Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo. Rituparna Das, Rakesh Verma, +8 authors, Mario Sznol, Chandra Sekhar Boddupalli, Scott N Gettinger, Harriet Kluger, Margaret Callahan, Jedd D Wolchok, Ruth Halaban, Madhav V Dhodapkar, Kavita M Dhodapkar. less J Immunol, 2014 Dec 30; 194(3). PMID: 25539810 Free PMC article. Highly Cited.
|
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study. Scott Antonia, Sarah B Goldberg, +8 authors, Ani Balmanoukian, Jamie E Chaft, Rachel E Sanborn, Ashok Gupta, Rajesh Narwal, Keith Steele, Yu Gu, Joyson J Karakunnel, Naiyer A Rizvi. less Lancet Oncol, 2016 Feb 10; 17(3). PMID: 26858122 Free PMC article. Highly Cited.
|
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination. Celine Boutros, Ahmad Tarhini, +14 authors, Emilie Routier, Olivier Lambotte, Francois Leroy Ladurie, Franck Carbonnel, Hassane Izzeddine, Aurelien Marabelle, Stephane Champiat, Armandine Berdelou, Emilie Lanoy, Matthieu Texier, Cristina Libenciuc, Alexander M M Eggermont, Jean-Charles Soria, Christine Mateus, Caroline Robert. less Nat Rev Clin Oncol, 2016 May 05; 13(8). PMID: 27141885 Highly Cited. Review.
|
Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells. Shan Chung, Yuwen L Lin, +6 authors, Chae Reed, Carl Ng, Zhijie Jey Cheng, Fabio Malavasi, Jihong Yang, Valerie Quarmby, An Song. less J Immunol Methods, 2014 Apr 08; 407. PMID: 24704820
|
The Ki-67 protein: from the known and the unknown. T Scholzen, J Gerdes. J Cell Physiol, 2000 Feb 01; 182(3). PMID: 10653597 Highly Cited. Review.
|
Genetic basis for clinical response to CTLA-4 blockade in melanoma. Alexandra Snyder, Vladimir Makarov, +18 authors, Taha Merghoub, Jianda Yuan, Jesse M Zaretsky, Alexis Desrichard, Logan A Walsh, Michael A Postow, Phillip Wong, Teresa S Ho, Travis J Hollmann, Cameron Bruggeman, Kasthuri Kannan, Yanyun Li, Ceyhan Elipenahli, Cailian Liu, Christopher T Harbison, Lisu Wang, Antoni Ribas, Jedd D Wolchok, Timothy A Chan. less N Engl J Med, 2014 Nov 20; 371(23). PMID: 25409260 Free PMC article. Highly Cited.
|
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. E A Tivol, F Borriello, +3 authors, A N Schweitzer, W P Lynch, J A Bluestone, A H Sharpe. less Immunity, 1995 Nov 01; 3(5). PMID: 7584144 Highly Cited.
|
CTLA-4 antibodies: new directions, new combinations. Samuel A Funt, David B Page, Jedd D Wolchok, Michael A Postow. Oncology (Williston Park), 2014 Nov 13; 28 Suppl 3. PMID: 25387681 Review.
|
T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor. Elke Valk, Rufina Leung, +3 authors, Hyun Kang, Kazuyo Kaneko, Christopher E Rudd, Helga Schneider. less Immunity, 2006 Oct 31; 25(5). PMID: 17070077
|
Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. T Moreau, A Coles, +4 authors, M Wing, J Isaacs, G Hale, H Waldmann, A Compston. less Brain, 1996 Feb 01; 119 ( Pt 1). PMID: 8624684
|
Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies. Yannick Bulliard, Rose Jolicoeur, +6 authors, Maurice Windman, Sarah M Rue, Seth Ettenberg, Deborah A Knee, Nicholas S Wilson, Glenn Dranoff, Jennifer L Brogdon. less J Exp Med, 2013 Jul 31; 210(9). PMID: 23897982 Free PMC article. Highly Cited.
|
OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy. Yannick Bulliard, Rose Jolicoeur, +3 authors, Jimin Zhang, Glenn Dranoff, Nicholas S Wilson, Jennifer L Brogdon. less Immunol Cell Biol, 2014 Apr 16; 92(6). PMID: 24732076 Highly Cited.
|
Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. C C Stamper, Y Zhang, +7 authors, J F Tobin, D V Erbe, S Ikemizu, S J Davis, M L Stahl, J Seehra, W S Somers, L Mosyak. less Nature, 2001 Mar 30; 410(6828). PMID: 11279502 Highly Cited.
|
Retrocyte Display® technology: generation and screening of a high diversity cellular antibody library. Ekaterina Breous-Nystrom, Kornelia Schultze, +10 authors, Marco Meier, Lukas Flueck, Christina Holzer, Melanie Boll, Volker Seibert, Andrea Schuster, Milan Blanusa, Verena Schaefer, Ulf Grawunder, Luis Martin-Parras, Marc A van Dijk. less Methods, 2013 Sep 17; 65(1). PMID: 24036249
|
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Hye Sun Kuehn, Weiming Ouyang, +33 authors, Bernice Lo, Elissa K Deenick, Julie E Niemela, Danielle T Avery, Jean-Nicolas Schickel, Dat Q Tran, Jennifer Stoddard, Yu Zhang, David M Frucht, Bogdan Dumitriu, Phillip Scheinberg, Les R Folio, Cathleen A Frein, Susan Price, Christopher Koh, Theo Heller, Christine M Seroogy, Anna Huttenlocher, V Koneti Rao, Helen C Su, David Kleiner, Luigi D Notarangelo, Yajesh Rampertaap, Kenneth N Olivier, Joshua McElwee, Jason Hughes, Stefania Pittaluga, Joao B Oliveira, Eric Meffre, Thomas A Fleisher, Steven M Holland, Michael J Lenardo, Stuart G Tangye, Gulbu Uzel. less Science, 2014 Sep 13; 345(6204). PMID: 25213377 Free PMC article. Highly Cited.
|
B70 antigen is a second ligand for CTLA-4 and CD28. M Azuma, D Ito, +4 authors, H Yagita, K Okumura, J H Phillips, L L Lanier, C Somoza. less Nature, 1993 Nov 04; 366(6450). PMID: 7694153 Highly Cited.
|
M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro. Marzia Leidi, Elisa Gotti, +7 authors, Luca Bologna, Elena Miranda, Monica Rimoldi, Antonio Sica, Massimo Roncalli, Giuseppe A Palumbo, Martino Introna, Josée Golay. less J Immunol, 2009 Mar 21; 182(7). PMID: 19299742 Highly Cited.
|
CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. P A van der Merwe, D L Bodian, +2 authors, S Daenke, P Linsley, S J Davis. less J Exp Med, 1997 Feb 03; 185(3). PMID: 9053440 Free PMC article. Highly Cited.
|
Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Jackson G Egen, James P Allison. Immunity, 2002 Feb 05; 16(1). PMID: 11825563 Highly Cited.
|
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Omar S Qureshi, Yong Zheng, +12 authors, Kyoko Nakamura, Kesley Attridge, Claire Manzotti, Emily M Schmidt, Jennifer Baker, Louisa E Jeffery, Satdip Kaur, Zoe Briggs, Tie Z Hou, Clare E Futter, Graham Anderson, Lucy S K Walker, David M Sansom. less Science, 2011 Apr 09; 332(6029). PMID: 21474713 Free PMC article. Highly Cited.
|
Different adaptations of IgG effector function in human and nonhuman primates and implications for therapeutic antibody treatment. Max Warncke, Thomas Calzascia, +4 authors, Michele Coulot, Nicole Balke, Ratiba Touil, Frank Kolbinger, Christoph Heusser. less J Immunol, 2012 Mar 31; 188(9). PMID: 22461693
|
Cytokine release assays: current practices and future directions. D Finco, C Grimaldi, +12 authors, M Fort, M Walker, A Kiessling, B Wolf, T Salcedo, R Faggioni, A Schneider, A Ibraghimov, S Scesney, D Serna, R Prell, R Stebbings, P K Narayanan. less Cytokine, 2014 Jan 15; 66(2). PMID: 24412476 Review.
|
CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases. Christine Guntermann, Denis R Alexander. J Immunol, 2002 Apr 24; 168(9). PMID: 11970985
|
Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes. Lidia Robert, Christina Harview, +8 authors, Ryan Emerson, Xiaoyan Wang, Stephen Mok, Blanca Homet, Begonya Comin-Anduix, Richard C Koya, Harlan Robins, Paul C Tumeh, Antoni Ribas. less Oncoimmunology, 2014 Aug 02; 3. PMID: 25083336 Free PMC article.
|
Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. A S Freedman, G J Freeman, K Rhynhart, L M Nadler. Cell Immunol, 1991 Oct 15; 137(2). PMID: 1716521 Highly Cited.
|
The B7-CD28 superfamily. Arlene H Sharpe, Gordon J Freeman. Nat Rev Immunol, 2002 Mar 26; 2(2). PMID: 11910893 Highly Cited. Review.
|
Neoantigens in cancer immunotherapy. Ton N Schumacher, Robert D Schreiber. Science, 2015 Apr 04; 348(6230). PMID: 25838375 Highly Cited. Review.
|
T-cell-dependent antibody response: assay development in cynomolgus monkeys. Joseph R Piccotti, James D Alvey, James F Reindel, Roberto E Guzman. J Immunotoxicol, 2008 Oct 30; 2(4). PMID: 18958673
|
Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Nicholas S Wilson, Jose A Villadangos. Adv Immunol, 2005 Feb 12; 86. PMID: 15705424 Review.
|
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. Matthew D Hellmann, Naiyer A Rizvi, +14 authors, Jonathan W Goldman, Scott N Gettinger, Hossein Borghaei, Julie R Brahmer, Neal E Ready, David E Gerber, Laura Q Chow, Rosalyn A Juergens, Frances A Shepherd, Scott A Laurie, William J Geese, Shruti Agrawal, Tina C Young, Xuemei Li, Scott J Antonia. less Lancet Oncol, 2016 Dec 10; 18(1). PMID: 27932067 Free PMC article. Highly Cited.
|
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. James Larkin, Vanna Chiarion-Sileni, +28 authors, Rene Gonzalez, Jean Jacques Grob, C Lance Cowey, Christopher D Lao, Dirk Schadendorf, Reinhard Dummer, Michael Smylie, Piotr Rutkowski, Pier F Ferrucci, Andrew Hill, John Wagstaff, Matteo S Carlino, John B Haanen, Michele Maio, Ivan Marquez-Rodas, Grant A McArthur, Paolo A Ascierto, Georgina V Long, Margaret K Callahan, Michael A Postow, Kenneth Grossmann, Mario Sznol, Brigitte Dreno, Lars Bastholt, Arvin Yang, Linda M Rollin, Christine Horak, F Stephen Hodi, Jedd D Wolchok. less N Engl J Med, 2015 Jun 02; 373(1). PMID: 26027431 Free PMC article. Highly Cited.
|
Crystal structure of a SEA variant in complex with MHC class II reveals the ability of SEA to crosslink MHC molecules. Karin Petersson, Marjolein Thunnissen, Göran Forsberg, Björn Walse. Structure, 2002 Dec 07; 10(12). PMID: 12467569
|
CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic. Margaret K Callahan, Michael A Postow, Jedd D Wolchok. Front Oncol, 2015 Feb 03; 4. PMID: 25642417 Free PMC article. Highly Cited. Review.
|
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. Tyler R Simpson, Fubin Li, +11 authors, Welby Montalvo-Ortiz, Manuel A Sepulveda, Katharina Bergerhoff, Frederick Arce, Claire Roddie, Jake Y Henry, Hideo Yagita, Jedd D Wolchok, Karl S Peggs, Jeffrey V Ravetch, James P Allison, Sergio A Quezada. less J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981 Free PMC article. Highly Cited.
|
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. Aurélien Marabelle, Holbrook Kohrt, +13 authors, Idit Sagiv-Barfi, Bahareh Ajami, Robert C Axtell, Gang Zhou, Ranjani Rajapaksa, Michael R Green, James Torchia, Joshua Brody, Richard Luong, Michael D Rosenblum, Lawrence Steinman, Hyam I Levitsky, Victor Tse, Ronald Levy. less J Clin Invest, 2013 Jun 04; 123(6). PMID: 23728179 Free PMC article. Highly Cited.
|
Fcγ receptors enable anticancer action of proapoptotic and immune-modulatory antibodies. Jeong M Kim, Avi Ashkenazi. J Exp Med, 2013 Aug 28; 210(9). PMID: 23980122 Free PMC article. Review.
|